Value Line appoints Dr. Swistel to board, audit committee
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Value Line ( (VALU) ).
On December 6, 2025, long-serving Value Line, Inc. director Alfred R. Fiore, who had been on the company’s board since 2010, passed away. On January 16, 2026, the board appointed Dr. Alexander J. Swistel, a retired associate professor at Weill Cornell Medical College with degrees from Harvard University and Brown University School of Medicine, to fill a board seat and serve on the Audit Committee, with standard annual compensation of $40,000; the company emphasized that his selection involved no special arrangements, family relationships, or related-party transactions, underscoring governance independence and continuity in its audit oversight.
The most recent analyst rating on (VALU) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on Value Line stock, see the VALU Stock Forecast page.
Spark’s Take on VALU Stock
According to Spark, TipRanks’ AI Analyst, VALU is a Outperform.
Value Line’s overall stock score reflects strong technical indicators and a positive corporate event in the form of a stock repurchase program. While financial performance shows robust profitability and stability, concerns about declining revenue and cash flow growth rates need addressing. The valuation is reasonable, with an attractive dividend yield.
To see Spark’s full report on VALU stock, click here.
More about Value Line
Average Trading Volume: 3,405
Technical Sentiment Signal: Sell
Current Market Cap: $349.3M
See more data about VALU stock on TipRanks’ Stock Analysis page.
